Topics
- COVID-19 (102)
- Advertising (74)
- COVID-19 vaccines (63)
- Prescription medicines (29)
- Medical devices (20)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
294 result(s) found, displaying 71 to 80
- Media releasesTGA provisionally approves AstraZeneca's combination therapy (tixagevimab and cilgavimab, EVUSHELD) - for pre-exposure prevention (prophylaxis) of COVID-19The TGA has granted provisional approval to AstraZeneca Pty Ltd for its tixagevimab and cilgavimab (EVUSHELD) for the prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus, known as pre-exposure prevention of COVID-19.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 24-02-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesModerna's COVID-19 vaccine (SPIKEVAX) provisionally approved for use in individuals 6 years and olderThe TGA has provisionally approved the Moderna CoVID-19 vaccine, SPIKEVAX, for use in individuals 6 years and older.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 17-02-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTCF Trading Co Pty Ltd fined $13,320 for unlawful importation of COVID-19 rapid antigen testsThe TGA has issued an infringement notice of $13,320 to Victorian-based company TCF Trading Co Pty Ltd for alleged unlawful importation of COVID-19 rapid antigen tests.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 10-02-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA provisionally approves AstraZeneca's COVID-19 vaccine as booster doseThe TGA has provisionally approved the AstraZeneca COVID-19 vaccine, Vaxzevria, for use as a booster in individuals aged 18 years and over.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 03-02-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesPfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use as a booster in individuals aged 16-17 years oldThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 16 and 17 years old.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 27-01-2022Information about the TGA's safety monitoring of COVID-19 vaccines.